The new shot targets a highly contagious variant that is in wide circulation nationwide
Yucatan Peninsula's 30,200 Dengue Cases Disrupt Vacations
Throughout the global dengue fever outbreak in 2023, a top-rated Mexico destination suddenly became a substantive hot spot for this mosquito-transmitted disease.
According to Mexico's Health Ministry dengue report in October 2023, there were 30,320 confirmed dengue cases on the Yucatan Peninsula between January and October 7, 2023.
This data confirms dengue cases have increased in this area of Mexico by 337% this year.
Vaccination Coverage Increased in 2022, but Still Below 2019 Levels
Worldwide, 14.3 million children were not vaccinated with DTPcv1 in 2022, a decrease from 2021 and increase from 2019
Unique Workplace Concerns Tied to Health Worker Depression, Anxiety During Pandemic
Associations seen for working on the hospital unit, mood disturbances, and sleep disturbances with depression, anxiety
Self-Administered Nasal Flu Shot Approval Under FDA Review
For the first time, an influenza vaccine sprayed into the nose that protects people against the seasonal flu has been accepted for review by the U.S. Food and Drug Administration (FDA).
If approved by the FDA, FLUMIST® QUADRIVALENT will be the first live nasal influenza vaccine available to be self-administered by eligible patients or administered by caregivers.
Self-Administered Nasal Flu Shot Approval Under FDA Review
For the first time, an influenza vaccine sprayed into the nose that protects people against the seasonal flu has been accepted for review by the U.S. Food and Drug Administration (FDA).
If approved by the FDA, FLUMIST® QUADRIVALENT will be the first live nasal influenza vaccine available to be self-administered by eligible patients or administered by caregivers.
Women Intentionally Infected With Zika Virus During Clinical Trial
For the first time, scientists deliberately infected women with the Zika virus to learn whether such a strategy could help test vaccine candidates against the pathogen, wrote Mariana Lenharo in a recent article published by the journal Nature.
These study participants who were infected only reported mild symptoms.
Non-Muscle-Invasive Bladder Cancer Vaccine Candidate Competes Resubmission to US FDA
When the U.S. Food and Drug Administration (FDA) issued a complete response letter in May 2023, it indicated that the agency could not approve the biologics license application (BLA) for a Non-Muscle-Invasive Bladder Cancer (NMIBC) vaccine candidate, thousands of people impacted by this common cancer were disappointed.
Study Identifies Parent/Caregiver COVID-19 Vaccine Concerns
Focus groups report that infertility is a common concern in addition to other general concerns about vaccines
Telemedicine Feasible for Buprenorphine Initiation in Opioid Use Disorder
Higher 90-day treatment retention rates seen with no higher risk for overdose